Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Appointed CFO
Director departure
Inv. presentation
Quarterly results
Consulting agrmnt
|
|
Alliqua BioMedical, Inc. (ADYX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2019 |
GN
| Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical |
| 05/06/2019 |
GN
| Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors |
| 04/22/2019 |
GN
| Alliqua BioMedical CEO Provides Update to Shareholders |
| 04/11/2019 |
GN
| Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business |
| 01/03/2019 |
GN
| Alliqua Biomedical CEO Provides Update to Shareholders |
| 10/12/2018 |
GN
| Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation |
| 05/07/2018 |
GN
| Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc. |
| 01/05/2018 |
GN
| Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc. |
| 11/09/2017 |
GN
| Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook |
| 11/09/2017 |
GN
| Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives |
| 08/10/2017 |
GN
| Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results |
| 07/26/2017 |
GN
| Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10th |
| 06/19/2017 |
GN
| Alliqua BioMedical, Inc. Announces Partnership with Partners Capital Group to Provide UltraMIST® Customers with New Equipment Financing Programs |
| 05/09/2017 |
GN
| Alliqua BioMedical, Inc. Reports First Quarter of Fiscal Year 2017 Financial Results |
| 04/12/2017 |
GN
| Alliqua BioMedical, Inc. Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement |
| 04/06/2017 |
GN
| Alliqua BioMedical, Inc. Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook; Earnings Conference Call Scheduled for May 9, 2017 |
| 04/03/2017 |
GN
| Alliqua BioMedical, Inc. Announces Closing of Approximately $3.8 Million Public Offering |
| 03/28/2017 |
GN
| Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock |
| 03/20/2017 |
GN
| Alliqua BioMedical, Inc. Announces the Publication of a Peer-reviewed Study Examining the Use of MIST Therapy for Deep Tissue Pressure Injuries |
| 03/02/2017 |
GN
| Alliqua BioMedical, Inc. to Present at the Cowen and Company 37th Annual Health Care Conference on March 8th |
| 03/01/2017 |
GN
| Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2016 Results on March 7th |
| 02/28/2017 |
GN
| Alliqua BioMedical, Inc. Announces the Closing of Approximately $2.8 Million Private Placement |
| 02/28/2017 |
GN
| Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC |
| 01/31/2012 |
GN
| Alliqua, Inc. Provides Corporate Update, Plans for 2012 |
| 07/20/2011 |
GN
| CORRECTING AND REPLACING: Alliqua, Inc. Acquires Exclusive License to Antimicrobial Wound Care Products from Noble Biomaterials, Inc. |
| 07/20/2011 |
GN
| Alliqua, Inc. Acquires Exclusive License to Antimicrobial Wound Care Products From Noble Biomaterials, Inc. |
| 04/12/2011 |
GN
| Alliqua, Inc. Files Provisional Patent in the U.S. for Transdermal Delivery System |
|
|